Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
228
Frequently Asked Questions
What is Market Cap of Coherus Oncology Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Coherus Oncology Inc. market cap is $188.29M.
What is the 52-week high for Coherus Oncology Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Coherus Oncology Inc. 52 week high is $2.43 as of October 02, 2025.
What is the 52-week low for Coherus Oncology Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Coherus Oncology Inc. 52 week low is $0.6603 as of October 02, 2025.
What is Coherus Oncology Inc. stock price today?
Coherus Oncology Inc. stock price today is $1.66.
What was Coherus Oncology Inc. stock price yesterday?
Coherus Oncology Inc. stock price yesterday was $1.62.
What is the PE ratio of Coherus Oncology Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Coherus Oncology Inc.’s P/E ratio is -1.18.
What is the Price-to-Book ratio of Coherus Oncology Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Coherus Oncology Inc. P/B ratio is 1.5713.
What is the 50-day moving average of Coherus Oncology Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Coherus Oncology Inc. 50-day moving average is $1.20.
How many employess does Coherus Oncology Inc. has?